<?xml version="1.0" encoding="UTF-8"?>
<ref id="R30">
 <label>30.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lingappa</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Baeten</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Wald</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Hughes</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>KK</given-names>
   </name>
   <name>
    <surname>Mujugira</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <collab>Partners in Prevention HSV/HIV Transmission Study Team</collab>. 
  <article-title>Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial</article-title>. 
  <source>
   <italic>Lancet</italic>
  </source>
  <year>2010</year>; 
  <volume>375</volume>:
  <fpage>824</fpage>â€“
  <lpage>833</lpage>.
  <pub-id pub-id-type="pmid">20153888</pub-id>
 </mixed-citation>
</ref>
